These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3054922

  • 1. Ornithine decarboxylase as a marker for colorectal polyps and cancer.
    Luk GD, Moshier JA, Ehrinpreis MN.
    Prog Clin Biol Res; 1988; 279():227-39. PubMed ID: 3054922
    [Abstract] [Full Text] [Related]

  • 2. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia.
    Braverman DZ, Stankiewicz H, Goldstein R, Patz JK, Morali GA, Jacobsohn WZ.
    Am J Gastroenterol; 1990 Jun; 85(6):723-6. PubMed ID: 2353692
    [Abstract] [Full Text] [Related]

  • 3. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
    Hixson LJ, Garewal HS, McGee DL, Sloan D, Fennerty MB, Sampliner RE, Gerner EW.
    Cancer Epidemiol Biomarkers Prev; 1993 Jun; 2(4):369-74. PubMed ID: 8348060
    [Abstract] [Full Text] [Related]

  • 4. Biochemical markers in colorectal cancer: diagnostic and therapeutic implications.
    Luk GD, Desai TK, Conteas CN, Moshier JA, Silverman AL.
    Gastroenterol Clin North Am; 1988 Dec; 17(4):931-40. PubMed ID: 3068151
    [Abstract] [Full Text] [Related]

  • 5. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
    Love RR, Surawicz TS, Morrissey JF, Verma AK.
    Cancer Epidemiol Biomarkers Prev; 1992 Dec; 1(3):195-8. PubMed ID: 1306105
    [Abstract] [Full Text] [Related]

  • 6. Ornithine decarboxylase as a biologic marker in familial colonic polyposis.
    Luk GD, Baylin SB.
    N Engl J Med; 1984 Jul 12; 311(2):80-3. PubMed ID: 6738598
    [Abstract] [Full Text] [Related]

  • 7. Biochemical markers in patients with familial colonic neoplasia.
    Luk GD, Silverman AL, Giardiello FM.
    Semin Surg Oncol; 1987 Jul 12; 3(2):126-32. PubMed ID: 3035686
    [Abstract] [Full Text] [Related]

  • 8. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M, Drullinsky P, Guillem J, Moore MA.
    Clin Cancer Res; 1997 Nov 12; 3(11):1931-41. PubMed ID: 9815582
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D, Goulão MH, Camacho E, Figueiredo P, Ministro P, Ferreira M, Portela F, Andrade P, Donato A, Martins MI.
    Hepatogastroenterology; 2002 Nov 12; 49(47):1269-74. PubMed ID: 12239922
    [Abstract] [Full Text] [Related]

  • 11. Supplemental calcium suppresses colonic mucosal ornithine decarboxylase activity in elderly patients with adenomatous polyps.
    Lans JI, Jaszewski R, Arlow FL, Tureaud J, Luk GD, Majumdar AP.
    Cancer Res; 1991 Jul 01; 51(13):3416-9. PubMed ID: 1711410
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G, Müller-Ruchholtz W.
    Cancer Detect Prev; 2001 Jul 01; 25(4):344-51. PubMed ID: 11531011
    [Abstract] [Full Text] [Related]

  • 16. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G, Paganelli GM, Santucci R, Brandi G, Barbara L.
    J Cell Biochem Suppl; 1994 Jul 01; 19():55-60. PubMed ID: 7823606
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.
    von Kleist S, Hesse Y, Kananeeh H.
    Anticancer Res; 1996 Jul 01; 16(4B):2325-31. PubMed ID: 8694564
    [Abstract] [Full Text] [Related]

  • 18. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T, Ota J, Sumida S, Rii M.
    Gan To Kagaku Ryoho; 1987 Nov 01; 14(11):3004-9. PubMed ID: 3479051
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A.
    Nuklearmedizin; 1986 Feb 01; 25(1):9-14. PubMed ID: 3459133
    [Abstract] [Full Text] [Related]

  • 20. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M.
    Pol Merkur Lekarski; 2002 Jan 01; 12(67):77-80. PubMed ID: 11957811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.